rolofylline
Sponsors
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Merck Sharp & Dohme LLC
Conditions
Heart FailureHeart Failure, Congestive
Phase 2
Phase 3
PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
CompletedNCT00328692
Start: 2006-08-31End: 2009-07-31Updated: 2009-10-09
PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
CompletedNCT00354458
Start: 2006-10-31End: 2009-07-31Updated: 2009-10-09
Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy
CompletedNCT00443690
Start: 2007-08-31End: 2009-01-31Target: 480Updated: 2009-02-20